Skip to main content
. 2019 Mar 8;2(3):e190005. doi: 10.1001/jamanetworkopen.2019.0005

Table 2. Observed Outcomes by Treatment Group Using Testing Data, Stratified by Subgroup Identified Using Training Data.

Primary Composite Outcomea No. of Patients (No. of Events) HR (95% CI) P Value
Treated Control
Overall 2354 (121) 2326 (160) 0.7 (0.6-0.9) .02
Subgroups .02b
Current smokers with baseline systolic blood pressure >144 mm Hg 110 (12) 126 (6) 10.6 (1.3-86.1) .03
Remainder of trial population 2244 (109) 2200 (154) 0.7 (0.5-0.9) .003

Abbreviation: HR, hazard ratio.

a

Includes myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death due to cardiovascular causes.

b

P value for the interaction term; false discovery rate for the interaction term is 0.007.